Page 10 - TT-TCCF_Annual_Report
P. 10

THE DISTRIBUTED CANCER CARE MODEL                                                        The year 2022-23 saw the successful culmination of 5
                                                                                                     years of dedicated e orts put in by the team of TCCF in
                                                                                                     setting up a comprehensive cancer care infrastructure
                                                                                                     across the country. The significant milestones achieved
                                      Centres comprise 300+ bed apex facilities, which are           during the period were:
                                      equipped with an entire array of oncology services,
                             L1       like radiation, medical, surgical, nuclear medicine and
                                      allied facilities including high-end lab services and             Inauguration of 7 cancer care hospitals in Assam by
                                      research facilities.
                                                                                                        Hon. Prime Minister in the presence of Chairman,
                                                                                                        Tata Trusts, in April’22. Foundation stones for another
                                                                                                        7 were also laid by the Hon’ble Prime Minister which is
                                                                                                        to be rolled out by Tata Trusts under Phase 2.
                                      L2 centres are approximately 100-bed hospitals
                            L2        annexed to Government Medical Colleges. They are
                                      equipped with comprehensive oncology services                     Sri Venkateswara Institute of Cancer Care and
                                      and allied facilities.                                            Advanced Research (SVICCAR), Tirupati, was
                                                                                                        inaugurated in May 22 by the Hon. Chief Minister of
                                                                                                        Andhra Pradesh.



                                                                                                        Ranchi Cancer Hospital and Research Centre (RCHRC),
                                      L3 centres are 40-bed facilities including diagnostic             commenced operations in September 2022 and was
                           L3 L3      and day-care radiotherapy and chemotherapy                        inaugurated in May 2023.
                                      units, set up adjacent to district hospitals or near
                                      medical colleges.

                                                                                                        Construction, equipping and handover of Zulekha
                                                                                                        Yenepoya Institute of Oncology, Mangalore to Yenepoya
                                                                                                        Medical College Hospital was completed in 2022
                                      L4 centres cover community interventions like
                                      awareness and early detection initiatives, including
                           L4 L4      palliative care to help in bringing down the disease              Construction and equipping handover of
                                      burden, and also reverse the early-to late-detection              Radiotherapy Block at Cachar Cancer Hospital
                                      ratio from 30:70 to 70:30.                                        Society, Silchar was completed in 2022







              08    Cancer Care Programme
   5   6   7   8   9   10   11   12   13   14   15